FCMI
MYOK

Foresite Capital Management IV’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Foresite Capital Management IV’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-126,492
Closed -$17.2M – 17
2020
Q3 		$17.2M Hold
126,492
– – 3.89% 9
2020
Q2 		$12.2M Sell
126,492
-180,908
-59% -$15.1M 5.95% 7
2020
Q1 		$14.4M Buy
307,400
+47,030
+18% +$3.01M 17.76% 2
2019
Q4 		$19M Buy
260,370
+22,184
+9% +$1.35M 8.19% 6
2019
Q3 		$12.4M Sell
238,186
-19,266
-7% -$1.02M 4.01% 11
2019
Q2 		$12.9M Sell
257,452
-127,541
-33% -$6.21M 3.65% 12
2019
Q1 		$20M Sell
384,993
-101,631
-21% -$4.68M 7.19% 7
2018
Q4 		$23.8M Sell
486,624
-24,620
-5% -$1.36M 10.91% 3
2018
Q3 		$33.3M Sell
511,244
-54,511
-10% -$3.21M 10.93% 2
2018
Q2 		$28.1M Buy
565,755
+173,800
+44% +$8.41M 9.58% 4
2018
Q1 		$19.1M Buy
391,955
+82,598
+27% +$4.29M 7.93% 5
2017
Q4 		$13M Buy
+309,357
New +$11.9M 9.13% 5

Foresite Capital Management IV's MYOK Position: Q4 2020 in Review

Foresite Capital Management IV sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 126,492 shares — an estimated $17.2M sold.

Foresite Capital Management IV first reported a position in MYOK in Q4 2017 and held it in 12 quarters. The position peaked at $33.3M in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Foresite Capital Management IV reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Foresite Capital Management IV sold 126,492 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $17.2M.
  • Foresite Capital Management IV first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 12 quarters.
  • Foresite Capital Management IV's MyoKardia, Inc. Common Stock position peaked at $33.3M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Foresite Capital Management IV's 13F filing for Q4 2020, filed 16 Feb 2021.